Spasticity and When It Requires a Baclofen Pump

Spasticity is velocity-dependent increased muscle tone from central nervous system injury to the corticospinal tract. It follows spinal cord injury, stroke, traumatic brain injury, multiple sclerosis, and cerebral palsy. Severity varies enormously from mild functional stiffness to severe uncontrolled spasms that make basic positioning, hygiene, and rehabilitation impossible.

According to Dr.Gurneet Singh Sawhney, Neurosurgeon in Mumbai, intrathecal baclofen works at doses 100 times lower than oral medication and that single difference is what eliminates the sedation and cognitive side effects that make oral baclofen impossible to sustain at therapeutic levels.

What Is Spasticity and How Does It Affect Function?

Spasticity is not stiffness. That distinction matters clinically because the two conditions require different treatments  and confusing them delays intervention that would have worked.

• Clinical features: Clasp-knife resistance on passive limb movement, exaggerated deep tendon reflexes, clonus, and involuntary flexor or extensor spasms define spasticity. Velocity-dependent resistance is the hallmark  the speed of passive movement during examination is what reveals or conceals the finding.
• Functional impact: Severe spasticity makes adequate wheelchair positioning impossible, causes skin breakdown from sustained abnormal postures, and destroys sleep through nocturnal spasms. And in children with cerebral palsy, spasticity left uncorrected causes progressive musculoskeletal deformity that later surgery simply cannot fully undo.
• First-line management: Physiotherapy, oral baclofen, tizanidine, dantrolene, and botulinum toxin for focal spasticity are established starting points. But oral baclofen causes sedation and cognitive impairment before therapeutic doses for generalised spasticity are reached  which is why intrathecal baclofen becomes the clinically appropriate option much sooner than most patients expect.
• Focal versus generalised: Focal single-limb spasticity responds well to botulinum toxin. Generalised spasticity across multiple limbs and trunk from spinal cord injury or cerebral palsy is a different problem entirely one that oral medication cannot adequately address without producing side effects that are themselves disabling.

Spasticity management requires clear assessment of distribution, severity, functional impact, and treatment goals. Without that assessment, the intervention selected is guesswork.

Explore functional neurosurgery in Mumbai for intrathecal baclofen pump evaluation at Fortis Hospital Mulund West.

When Does Spasticity Require an Intrathecal Baclofen Pump?

Intrathecal baclofen goes directly into the cerebrospinal fluid through a catheter in the intrathecal space. The required dose is approximately 100 times lower than oral medication. That is not a marginal difference it is why side effects disappear entirely while spasticity control becomes dramatically better than anything oral agents can produce.

• Failed oral medication: Oral baclofen, tizanidine, and dantrolene failing to achieve adequate control or producing intolerable sedation before therapeutic doses are reached  are the primary indications. Because oral baclofen has a narrow therapeutic window, many patients with generalised spasticity simply never get adequate control on tablets at all.
• Severe generalised spasticity: Patients with spinal cord injury, severe cerebral palsy, and progressive multiple sclerosis causing pain, positioning failure, and significant care burden are the strongest intrathecal baclofen pump candidates. The outcomes data consistently supports superiority over oral medication for this group  without exception.
• Positive baclofen trial: A single intrathecal test dose via lumbar puncture confirms clinical response before any pump implantation is scheduled. Adequate spasticity reduction following the trial is required before proceeding. Implanting without that confirmation is not standard practice it should never happen.
• Treatment goals: Ambulatory patients need selective reduction preserving useful tone for walking. Non-ambulatory patients need pain relief, positioning, and care. Because intrathecal baclofen affects the entire lower limb and trunk distribution, what the patient specifically needs must be established before implantation is even planned.

Families who have read about whether neurological problems can exist with normal scans understand why neurological examination and functional assessment determine management rather than imaging alone.

Why Choose Dr.Gurneet Singh Sawhney?

Dr. Gurneet Singh Sawhney completed dedicated fellowships in functional neurosurgery under Prof. Taira at Tokyo Women’s Medical University and epilepsy surgery under Prof. Sugano at Juntendo University both high-volume academic centres where intrathecal drug delivery and functional neurosurgical procedures formed a core part of the caseload. At Fortis Hospital Mulund West, spasticity cases receive neurological examination, functional evaluation, and a confirmed baclofen trial before pump implantation is recommended.

Patients receive a direct assessment covering spasticity severity, functional impact, treatment goals, and whether intrathecal baclofen is the right intervention for that specific case. Not a generic recommendation an objective plan built around what that individual patient actually needs.